Authors reponse: "Clinical characteristics, physiological features, and outcomes associated with hypercapnia in patients with acute hypoxemic respiratory failure due to COVID-19-Insights from the PRoVENT-COVID study".
作者信息
Tsonas Anissa M, Schultz Marcus J, Paulus Frederique
机构信息
Department of Intensive Care, Amsterdam UMC, location 'AMC', Amsterdam, the Netherlands.
Department of Intensive Care, Amsterdam UMC, location 'AMC', Amsterdam, the Netherlands; Mahidol-Oxford Tropical Medicine Research Unit (MORU), Mahidol University, Bangkok, Thailand; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
出版信息
J Crit Care. 2023 Feb;73:154178. doi: 10.1016/j.jcrc.2022.154178. Epub 2022 Oct 27.
Abstract
摘要
相似文献
1
Authors reponse: "Clinical characteristics, physiological features, and outcomes associated with hypercapnia in patients with acute hypoxemic respiratory failure due to COVID-19-Insights from the PRoVENT-COVID study".作者回复：“新型冠状病毒肺炎所致急性低氧性呼吸衰竭患者高碳酸血症的临床特征、生理特征及相关结局——来自PRoVENT-COVID研究的见解”
J Crit Care. 2023 Feb;73:154178. doi: 10.1016/j.jcrc.2022.154178. Epub 2022 Oct 27.
2
Letter to the editor: "Clinical characteristics, physiological features, and outcomes associated with hypercapnia in patients with acute hypoxemic respiratory failure due to COVID-19---insights from the PRoVENT-COVID study".致编辑的信：“新型冠状病毒肺炎所致急性低氧性呼吸衰竭患者高碳酸血症的临床特征、生理特征及预后——来自PRoVENT-COVID研究的见解”
J Crit Care. 2023 Feb;73:154177. doi: 10.1016/j.jcrc.2022.154177. Epub 2022 Oct 26.
3
Clinical characteristics, physiological features, and outcomes associated with hypercapnia in patients with acute hypoxemic respiratory failure due to COVID-19---insights from the PRoVENT-COVID study.COVID-19 所致急性低氧性呼吸衰竭患者高碳酸血症的临床特征、生理特征及结局：来自 PRoVENT-COVID 研究的观察。
J Crit Care. 2022 Jun;69:154022. doi: 10.1016/j.jcrc.2022.154022. Epub 2022 Mar 24.
4
Nondyspnogenic acute hypoxemic respiratory failure in COVID-19 pneumonia.新型冠状病毒肺炎中的非缺氧性急性低氧血症呼吸衰竭
J Appl Physiol (1985). 2021 Mar 1;130(3):892-897. doi: 10.1152/japplphysiol.00522.2020. Epub 2020 Oct 8.
5
Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial.急性低氧性呼吸衰竭和 COVID-19 患者应用无创性呼吸策略对插管或死亡率的影响：RECOVERY-RS 随机临床试验。
JAMA. 2022 Feb 8;327(6):546-558. doi: 10.1001/jama.2022.0028.
6
Practice of tracheostomy in patients with acute respiratory failure related to COVID-19 - Insights from the PRoVENT-COVID study.COVID-19 相关急性呼吸衰竭患者的气管切开术实践——来自 PRoVENT-COVID 研究的见解。
Pulmonology. 2022 Jan-Feb;28(1):18-27. doi: 10.1016/j.pulmoe.2021.08.012. Epub 2021 Sep 20.
7
Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19.新型冠状病毒肺炎所致急性低氧性呼吸衰竭患者的无创呼吸策略与气管插管或死亡率
JAMA. 2022 May 24;327(20):2022-2023. doi: 10.1001/jama.2022.5273.
8
Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19.新型冠状病毒肺炎所致急性低氧性呼吸衰竭患者的无创呼吸策略与气管插管或死亡率
JAMA. 2022 May 24;327(20):2023. doi: 10.1001/jama.2022.5276.
9
Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19-Reply.新型冠状病毒肺炎所致急性低氧性呼吸衰竭患者的无创呼吸策略与气管插管或死亡率——回复
JAMA. 2022 May 24;327(20):2023-2024. doi: 10.1001/jama.2022.5279.
10
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial.新冠肺炎合并中重度低氧血症呼吸衰竭患者使用头盔无创通气与高流量鼻导管吸氧治疗后脱机时间的影响：HENIVOT 随机临床试验
JAMA. 2021 May 4;325(17):1731-1743. doi: 10.1001/jama.2021.4682.
本文引用的文献
1
Association of early positive end-expiratory pressure settings with ventilator-free days in patients with coronavirus disease 2019 acute respiratory distress syndrome: A secondary analysis of the Practice of VENTilation in COVID-19 study.新冠肺炎急性呼吸窘迫综合征患者早期呼气末正压设置与呼吸机使用天数的关系：COVID-19 通气实践研究的二次分析。
Eur J Anaesthesiol. 2021 Dec 1;38(12):1274-1283. doi: 10.1097/EJA.0000000000001565.
2
Dead space estimates may not be independently associated with 28-day mortality in COVID-19 ARDS.估算的死腔量可能与 COVID-19 所致 ARDS 的 28 天死亡率无关。
Crit Care. 2021 May 17;25(1):171. doi: 10.1186/s13054-021-03570-0.
3
Associations of Body Mass Index with Ventilation Management and Clinical Outcomes in Invasively Ventilated Patients with ARDS Related to COVID-19-Insights from the PRoVENT-COVID Study.体重指数与2019冠状病毒病相关急性呼吸窘迫综合征有创通气患者通气管理及临床结局的关联——来自PRoVENT-COVID研究的见解
J Clin Med. 2021 Mar 11;10(6):1176. doi: 10.3390/jcm10061176.
4
Ventilatory Variables and Mechanical Power in Patients with Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征患者的通气变量和机械功率。
Am J Respir Crit Care Med. 2021 Aug 1;204(3):303-311. doi: 10.1164/rccm.202009-3467OC.
5
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.拯救脓毒症运动：脓毒症和脓毒性休克管理国际指南：2016 年版。
Intensive Care Med. 2017 Mar;43(3):304-377. doi: 10.1007/s00134-017-4683-6. Epub 2017 Jan 18.
6
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.与传统潮气量相比，采用较低潮气量对急性肺损伤和急性呼吸窘迫综合征进行通气治疗。
N Engl J Med. 2000 May 4;342(18):1301-8. doi: 10.1056/NEJM200005043421801.
Zotero 插件